Oct 6- Advaxis Inc said the U.S. Food and Drug Administration has put on hold the mid-stage trials of its experimental cancer drug after a patient died, sending its shares down 27 percent in extended trading. The clinical hold on the drug, axalimogene filolisbac, was issued after Advaxis submitted a safety report to the FDA, the company said on Tuesday.» Read More
Jason Votruba is big on small-cap stocks. The five-star fund manager says small caps are "outperforming, to the surprise of a lot of people, many of the large caps."
Putnam's Kevin Divney sees a dramatic difference between the tech-gadget company and the Web portal -- and offers advice on owning their stocks.
Philip Duff of Duff Capital Advisors offers CNBC the hedge-fund view of where Merrill Lynch, regional banks, the markets and oil are headed.
Two strategists, Stephen Wood at Russell Investments and John Manley at Citi Smith Barney, shared their market rebound strategies with CNBC.
Top Wall Street executives are in consensus: They believe the SEC is going to expand limits on short trading -- beyond what was initially targeted.
Mary Jane Matts knows a few things about "up" stocks in a "down" market, and she's sharing a couple of suggestions with CNBC.
Tumbling oil prices should send investors toward the people who own and run refineries, says SmartMoney senior markets editor Russell Pearlman.
Merrill Lynch, Amgen, and some medical instrument outfits are getting a lot of options action this week, according to one observer.
Jon Hilsenrath of The Wall Street Journal offered his weekly "Five for five": the five companies and their stocks that you must pay attention to this week.
The failure of IndyMac has terrified some investors about regional banks. Sandler O'Neill banking analyst Kevin Fitzsimmons is picking stocks carefully.
It may be difficult, but it is possible to live without oil. But that cannot be said for water. Debra Coy is making water flow into investors' portfolios.
Where are gold prices going? Gold can either consolidate through until Sept. 12 and then make a breakout from the $957 level -- or it can trade up to $1023.72 by Aug. 21, says Richard Morrish from MIG Investments.
Some of the world's red-hot economies may be losing their clout, but Peter Andersen still thinks American companies with significant international exposure are the best ideas for investors.
Looking to get your portfolio back on its feet? Susquehanna Financial Group's John Shanley says stocks of certain shoe companies are some of the best buys on the market today.
"The whole world is negative, and scared to death," but Bill Spiropoulos sees opportunities all over the place -- from global infrastructure build-out to consumer stocks.
Options trading: What clues are there for investors? Jon Najarian, OptionMonster.com co-founder and frequent Fast Money guest, offered CNBC his insights on Friday's options action.
David Goldberg, analyst at UBS, gives investors some stock tips on some homebuilding companies.
America's electric utilities are about to sink a small fortune into an upgrade of the U.S. power grid. How can an investor plug in? JPMorgan's Andrew Smith has some ideas.
David Sowerby's top stock pick is a homebuilder! The chief market analyst at Loomis Sayles cites "quality" -- and he also carefully selected a couple of tech companies...
No oil here. Bob Pisani talks up a new Middle East-oriented ETF: The Van Eck Market Vectors Gulf States Index. It offers investors access to 40 companies, based in key U.S. allies Bahrain, Kuwait, Oman and the UAE. But no oil firms are involved...